The limitation of this study is that we did not conduct relevant cell biology experiments to explore the effects of VRK2 on the proliferation, apoptosis, invasion, and metastasis of NPC cells, so as to further confirm that VRK2 may be a biomarker for predicting metastasis in patients with NPC after treatment. This evidence concerns the gene VRK2 and nasopharyngeal carcinoma.